Assembly Biosciences (ASMB) Other Accumulated Expenses (2018 - 2026)

Assembly Biosciences' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 26.97% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 26.97% YoY), while the FY2025 annual figure was $7.7 million, up 12.93% from the prior year.
• Other Accumulated Expenses was $1.5 million for Q1 2026 at Assembly Biosciences, down from $7.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $7.7 million in Q4 2025 to a low of $1.5 million in Q1 2026.
• Historically, Other Accumulated Expenses has averaged $4.3 million across 5 years, with a median of $3.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 115.21% in 2022, then tumbled 57.12% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $7.3 million in 2022, then slipped by 21.5% to $5.7 million in 2023, then grew by 19.46% to $6.9 million in 2024, then rose by 12.93% to $7.7 million in 2025, then sank by 80.15% to $1.5 million in 2026.
• The last three Other Accumulated Expenses figures came in at $1.5 million (Q1 2026), $7.7 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.